In this photo illustration, Danaher Corporation logo is seen displayed on a smartphone and PC screen.
Pavlo Gonchar | SOPA Images | LightRocket | Getty Images
Life sciences and medical diagnostics company Danaher (DHR) delivered a first-quarter earnings beat Tuesday, even as its lowered outlook sent shares of the Club holding tumbling. The revised guidance forces us to put our rating on Danaher stock under review, while lowering our price target.